PMID-16539679 – DSIP A Still Unresolved Riddle
Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. J Neurochem. 2006;97(2):303-309.
Quick Reference
| Property | Value |
|---|---|
| PMID | 16539679 |
| DOI | 10.1111/j.1471-4159.2006.03693.x |
| Year | 2006 |
| Journal | Journal of Neurochemistry |
| Study Type | Narrative Review |
| Evidence Level | V |
| Sample | N/A (comprehensive review spanning 30 years of DSIP research) |
| Peptide(s) Studied | DSIP |
Key Findings
- DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) has been studied for over 30 years with paradoxically inconsistent sleep-promoting results across different laboratories and experimental conditions
- DSIP demonstrates significant stress-protective effects, normalizing physiological parameters disrupted by various stressors in animal models
- The peptide interacts with opioid systems, showing modulatory effects on endogenous opioid signaling without acting as a direct opioid receptor agonist
- DSIP exhibits circadian rhythm normalization properties, potentially acting more as a sleep modulator/regulator than a direct sleep inducer
- No specific DSIP receptor has been identified despite decades of research, complicating mechanistic understanding
- DSIP has shown effects on thermoregulation, pain modulation, and neuroendocrine function beyond its sleep-related actions
Study Design
Comprehensive narrative review covering the full history of DSIP research from its discovery in 1977 through 2006. Reviews sleep studies, stress models, opioid interaction data, circadian experiments, and clinical observations. Critically evaluates reproducibility issues and methodological factors that may explain inconsistent findings across laboratories.
Limitations
- Narrative review with inherent selection bias
- Highlights the fundamental challenge that DSIP research suffers from poor reproducibility across labs
- Much early research used impure peptide preparations, confounding historical results
- No specific receptor identified, limiting mechanistic interpretation
- Many cited studies are from the 1980s-1990s with outdated methodologies
Clinical Relevance
This review provides essential context for understanding DSIP's complex pharmacology. The key clinical insight is that DSIP may function more as a sleep and stress modulator/normalizer rather than a conventional sedative — it tends to restore disrupted sleep patterns rather than induce sleep in normal subjects. Its stress-protective and circadian-normalizing properties may be more clinically relevant than direct sleep induction. Practitioners should understand that DSIP's mechanism remains incompletely characterized, and clinical expectations should be calibrated accordingly.
Related
#research #narrative-review #evidence-level-V